{
  "id": 16151078,
  "title": "+59%, +42%, +22%: Our AI just called these healthcare winners",
  "url": "https://urgent.news/2026/10/23/59-42-22-our-ai-just-called-these-healthcare-winners",
  "topic": "ai",
  "section": "AI",
  "published": "2026-10-23T04:32:17.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/59-42-22-our-ai-just-called-these-healthcare-winners-4968012"
  },
  "original_language": "en",
  "account": "In a recent development, an AI model identified healthcare as the top-performing sector within the S&P 500. The sector experienced a remarkable 9.02% gain throughout October. In contrast, technology saw a decline, with the Philadelphia Semiconductor Index dropping 6.72% on Thursday alone. Despite this, healthcare stocks were notable for their strong performance, with three AI-selected holdings showing significant gains.\n\nAmneal Pharmaceuticals, a mid-cap stock, emerged as the standout performer, surging 58.76% since April. The AI model purchased the stock at $12.90 on June 1, and it closed at $20.48 on Thursday. The company's second-quarter report, released on July 30, showed a 10% increase in net revenue to $796 million and a 17% rise in specialty sales. Adjusted EBITDA climbed 12% to $206 million, and adjusted earnings per share grew by 20% to $0.30. Management also raised full-year guidance for revenue and adjusted EBITDA, which could save the company around $12 million annually in interest.\n\nTenet Healthcare, another AI-selected stock, showcased impressive gains as well. The company's second-quarter results, announced on July 23, saw revenue rise 6.8% to $5.628 billion and adjusted EBITDA increase 16.3% to $1.304 billion. Tenet's ambulatory care business played a crucial role in this success. The company repurchased 5.68 million shares for $1.042 billion in the second quarter alone. However, exchange-related revenue fell 17% in the quarter, and Tenet's investments are susceptible to policy changes involving Affordable Care Act subsidies, which remain unpredictable for quantitative models.\n\nThe third and final AI-selected stock was Mettler-Toledo, added to the portfolio on September 1. The stock closed at $1,684.64 on Thursday, a 22.43% gain since selection, including a 13.74% increase this month. The model recognized Mettler-Toledo as a high-quality compounder whose shares had become undervalued. The company's second-quarter sales rose 7% to $1.03 billion, and adjusted earnings per share increased by 14% to $11.46. Management raised full-year adjusted earnings guidance to $47.15-$47.50 a share, with expected growth between 10% and 11%, compared to the previous 8% to 10% outlook. The stock is, however, valued at roughly 36 times the midpoint of its full-year earnings guidance.",
  "summary": null,
  "key_points": [
    "Healthcare sector gained 9.02% in October, outperforming technology",
    "Amneal Pharmaceuticals surged 58.76% since April, selected by AI",
    "Mettler-Toledo rose 22.43% since selection, identified as high-quality compounder"
  ],
  "editors_take": "The AI model's identification of healthcare winners highlights a shift toward defensive sectors as technology stocks falter and specific pharmaceutical and medical service holdings demonstrate resilient revenue growth.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}